FIELD: medicine.
SUBSTANCE: group of inventions concerns kallikrein, a version or fragment thereof having common epitopes recognized by antibodies with wild-type kallikrein used to prepare a diagnostic composition for in vitro diagnosing of type 1 allergy, wherein kallikrein is taken from a dog; a method for preparing a composition of allergens involving the stage of adding dog's kallikrein or version or fragment thereof; a method of kallikrein recovery from dog's urine.
EFFECT: higher sensitivity in diagnostic tests.
16 cl, 11 ex, 13 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ALLERGENS PRODUCED BY RECOMBINANT METHODS | 2010 |
|
RU2592674C2 |
| NEW ALLERGEN | 2011 |
|
RU2608494C2 |
| METHOD OF PRODUCING ALLERGEN EXTRACT | 2011 |
|
RU2706685C2 |
| METHOD OF OBTAINING ALLERGEN EXTRACT | 2011 |
|
RU2572230C2 |
| CALIBRATIONAL REAGENT AND METHOD | 2012 |
|
RU2629310C2 |
| RECOMBINANT POLYPEPTIDE BASED ON BIRCH POLLEN ALLERGEN AND APPLE ALLERGEN AS AN ALLERGY VACCINE | 2020 |
|
RU2761431C1 |
| ENZYME IMMUNOASSAY | 2012 |
|
RU2594066C2 |
| HYBRID PEPTIDE CARRYING PROTEINS AS VACCINES AGAINST ALLERGY | 2012 |
|
RU2630652C2 |
| METHOD OF IDENTIFYING ALLERGENIC PROTEINS AND PEPTIDES | 2009 |
|
RU2519674C2 |
| METHOD FOR ENCAPSULATING ALLERGENS INTO CHITOSAN PARTICLES TO REDUCE RECOGNITION OF ALLERGENS BY IgE ANTIBODIES DURING ALLERGEN-SPECIFIC SUBCUTANEOUS AND TRANSEPIDERMAL IMMUNOTHERAPY | 2020 |
|
RU2760672C1 |
